Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives

Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives

Major breakthroughs have been achieved in the management of metastatic pancreatic ductal adenocarcinoma (PDAC) with FOLFIRINOX (5-fluorouracil + irinotecan + oxaliplatin) and gemcitabine plus nab-paclitaxel approved as a first-line therapy, although the prognosis is still poor. At progression, patie...

Full description

Bibliographic Details
Main Authors:	Lisa Lellouche, Lola-Jade Palmieri, Solène Dermine, Catherine Brezault, Stanislas Chaussade, Romain Coriat
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-07-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359211018539

Similar Items

Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
by: Lola-Jade Palmieri, et al.
Published: (2020-06-01)

Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
by: Baptiste Camus, et al.
Published: (2021-03-01)

Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors
by: Solène Dermine, et al.
Published: (2019-11-01)

Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
by: Anna Pellat, et al.
Published: (2021-05-01)

Management of esophageal strictures after endoscopic resection for early neoplasia
by: Einas Abou Ali, et al.
Published: (2021-01-01)

Systemic therapy for metastatic pancreatic adenocarcinoma
by: Ben Lawrence, et al.
Published: (2010-03-01)

Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node Involvement
by: Solène Dermine, et al.
Published: (2020-12-01)

Biomarkers in pancreatic adenocarcinoma: current perspectives
by: Swords DS, et al.
Published: (2016-12-01)

The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review
by: Maxime Barat, et al.
Published: (2020-07-01)

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
by: Aleksandra Adamska, et al.
Published: (2017-06-01)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
by: Hossein Taghizadeh, et al.
Published: (2020-07-01)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
by: Demi S. Houg, et al.
Published: (2018-06-01)

AN UNUSUALLY PROLONGED SURVIVAL IN METASTATIC PERIAMPULLARY PANCREATIC ADENOCARCINOMA
by: Shafaq Maqsood, et al.
Published: (2016-12-01)

Chemokines and their receptors in the metastatic behaviour of human pancreatic ductal adenocarcinoma
by: Marchesi, Federica
Published: (2006)

Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma
by: Maxime Barat, et al.
Published: (2021-06-01)

Current and future biomarkers for pancreatic adenocarcinoma
by: Sven H Loosen, et al.
Published: (2017-05-01)

Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
by: Graziana Gallo, et al.
Published: (2020-04-01)

Colorectal cancer screening programme: is the French faecal immunological test (FIT) threshold optimal?
by: Anna Pellat, et al.
Published: (2021-05-01)

Is Endoscopic Submucosal Dissection the Option for Early Gastric Cancer Patients with Contraindication to Surgery
by: Said Farhat, et al.
Published: (2010-09-01)

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma
by: Anteneh A. Tesfaye, et al.
Published: (2019-05-01)

EUS-guided pancreatic radiofrequency ablation: preclinical comparison of two currently available devices in a pig model
by: Maximilien Barret, et al.
Published: (2019-01-01)

Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tract
by: Solène Dermine, et al.
Published: (2018-12-01)

Isolated metastatic pancreatic adenocarcinoma to the uterine cervix: A case report
by: Emily M. Hartsough, et al.
Published: (2019-08-01)

Desmoid Fibromatosis Mimicking Metastatic Recurrence After Pancreatectomy for Pancreatic Adenocarcinoma
by: Patrick Navin, MB BCh, BAO, et al.
Published: (2018-12-01)

Air circulation in a gastrointestinal light source box and endoscope in the era of SARS-CoV-2 and airborne transmission of microorganisms
by: Stanislas Chaussade, et al.
Published: (2021-02-01)

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan
by: Kenneth H. Yu, et al.
Published: (2021-07-01)

Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)

Genetic Mutation as a Predictive Biomarker for FOLFIRINOX in Patients with Metastatic Pancreatic Adenocarcinoma
by: Jaihwan Kim
Published: (2019-06-01)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01)

Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior
by: Tao Zhang, et al.
Published: (2020-06-01)

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
by: Jia-qiao Fan, et al.
Published: (2020-02-01)

Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies
by: Andrea Teague, et al.
Published: (2015-03-01)

Outcomes of esophagectomy after noncurative endoscopic resection of early esophageal cancer
by: Solène Dermine, et al.
Published: (2019-12-01)

Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
by: Fang Feng, et al.
Published: (2020-08-01)

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes
by: Eileen M. O'Reilly, et al.
Published: (2020-11-01)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01)

PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma
by: Ann E. Zeleniak, et al.
Published: (2018-01-01)

Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis
by: Muzikansky Alona, et al.
Published: (2009-03-01)

Target therapy in metastatic pheochromocytoma: current perspectives and controversies
by: Amrallah A. Mohammed, et al.
Published: (2014-09-01)

Endoscopic therapy in chronic pancreatitis: current perspectives
by: Seicean A, et al.
Published: (2014-12-01)